China has imposed new regulations on PRC companies raising foreign mid-to-long-term debt; It also has introduced stricter measures on bank asset risk classification; and for the first time, it has granted a wholly foreign-owned securities firm permission to be established in China.
2022 regulatory trends in China, including data protection, TMT, capital markets, PE/VC, IP, dispute resolution, healthcare, banking & finance, sanctions and antitrust.
US Congress passes Act to protect American intellectual property; China plans measures to boost foreign investment centrally and locally; and deals in the life sciences sector are subject to strong CFIUS scrutiny.
Nathan Bush, Nicholas Klein, Catherine Pawluch, and Alexandra Kamerling of DLA Piper survey the risks under the Foreign Direct Investment regimes of key jurisdictions, starting with the U.S., Canada, and the U.K. in this two-part series
Geoffrey Chan, Sophie Xue, and Nicholas Poon of Skadden, Arps, Slate, Meagher & Flom examine how the Hong Kong Limited Partnership Fund, which serves as a cost and tax efficient vehicle for private equity transactions, could become a popular alternative to traditional offshore fund structures for PE investments and fundraising in Greater China
New social credit draft law raises concerns for foreign companies; CSRC lifts ban on property M&A and refinancing; and U.K. government unwinds a completed transaction for the first time.
Three Chinese companies ordered out of Canada's lithium industry; CFIUS publishes first-ever enforcement and penalty guidelines; and China's metaverse IPO starts in Hong Kong.
A recent executive order issued by U.S. President Joe Biden heightened the level of scrutiny of inbound deals in certain sensitive industries. And now the U.S. is weighing legislation that calls for a "reverse CFIUS," which will add government scrutiny to outbound transactions.
CSRC plans to exempt foreign investors from short-term profit rules; Foshan Government vastly increases financial support for overseas IP protection; BNP Paribas gains regulatory approval from CBIRC for wealth management joint venture with Agricultural Bank of China.
As the relationship between the U.S. and China has deteriorated, an increasing number of Chinese companies are ending their U.S.-based operations. Derek Liu, Rod Hunter and Howard Wu of Baker McKenzie set out some guidance for those heading down that path